Astria Therapeutics
Stock Forecast, Prediction & Price Target

Astria Therapeutics Financial Estimates

Astria Therapeutics Revenue Estimates

Astria Therapeutics EBITDA Estimates

Astria Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $833.33K
Low: $833.33K
High: $833.33K
avg. 0%
Avg: $36.63M
Low: $36.63M
High: $36.63M
avg. 4296.01%
Avg: $262.28M
Low: $262.28M
High: $262.28M
avg. 615.96%
Net Income
 
% change YoY
$-30.17M
 
N/A
$-50.16M
 
-66.25%
$-72.89M
 
-45.30%
Avg: $-111.82M
Low: $-64.76M
High: $-38.25M
avg. -53.41%
Avg: $-124.31M
Low: $-62.05M
High: $-44.58M
avg. -11.16%
Avg: $-44.28M
Low: $-44.28M
High: $-44.28M
avg. 64.37%
Avg: $48.72M
Low: $48.72M
High: $48.72M
avg. 210.03%
EBITDA
 
% change YoY
$134.25M
 
N/A
$-53.50M
 
-139.85%
$-83.03M
 
-55.18%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$3.38
 
N/A
-$3.43
 
-1.47%
-$2.42
 
29.44%
Avg: -$1.7
Low: -$2.15
High: -$1.27
avg. 29.75%
Avg: -$1.78
Low: -$2.06
High: -$1.48
avg. -4.70%
Avg: -$1.47
Low: -$1.47
High: -$1.47
avg. 17.41%
Avg: $1.62
Low: $1.62
High: $1.62
avg. 210.03%
Operating Expenses
 
% change YoY
$30.35M
 
N/A
$53.50M
 
76.23%
$83.03M
 
55.18%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Astria Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 52.45% in 2025-2028.

We have gathered data from 5 analysts. Their low estimate is -64.76M, average is -111.82M and high is -38.25M.

What is Astria Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 1227.99% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Astria Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 63.12% in 2025-2028.

We have gathered data from 5 analysts. Their low earnings per share estimate is -$2.15, average is -$1.7 and high is $-1.27.

What is the best performing analyst?

In the last twelve months analysts have been covering Astria Therapeutics stock. The most successful analyst is Hartaj Singh.